Ordering Recommendation

FDA-approved test for routine cervical cancer screening in individuals ≥25 years of age with a cervix. Follow-up test for abnormal cytology results in individuals ≥21 years of age with a cervix.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation

Cervical, anal or vaginal specimens with SurePath collection kit and place in SurePath media.

Specimen Preparation

Transport original SurePath or briefly vortex and transfer 3 mL to an ARUP Standard Transport Tube. (Min 1.5 mL)

Storage/Transport Temperature


Unacceptable Conditions

Bloody or dark brown specimens. Specimens in any media other than indicated above.


Specimen source required.


Ambient: 1 month; Refrigerated: 6 months; Frozen: Unacceptable


Qualitative Polymerase Chain Reaction


Mon, Wed, Fri


1-5 days

Reference Interval


Interpretive Data

This test amplifies DNA of HPV16, HPV18 and 12 other high-risk HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) associated with cervical cancer and its precursor lesions. Sensitivity may be affected by specimen collection methods, stage of infection, and the presence of interfering substances. Results should be interpreted in conjunction with other available laboratory and clinical data. A negative high-risk HPV result does not exclude the presence of other high-risk HPV types.

HPV testing should not be used for screening or management of atypical squamous cells of undetermined significance (ASCUS) in women under age 21.

Compliance Category

Depends on Specimen/Source/Method


For cervical sources, a negative high-risk HPV result does not exclude the possibility of future cytologic abnormalities, underlying CIN2-3, or cancer.

Hotline History


CPT Codes



Component Test Code* Component Chart Name LOINC
0060752 HPV Source 31208-2
2011934 HPV Genotype 18 by PCR 77400-0
2011935 HPV Genotype 16 by PCR 77399-4
2011936 HPV, Other High Risk by PCR 82675-0
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.


  • HPV 16 18
  • HPV SurePath
  • HPV Typing
  • Human papilloma virus
Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by PCR, SurePath